Transference of the biotechnological investigation orientated to the managerial profitability and mobilization of flows of business


Biotransfer 2

Its main objective is to implement a profitable biotechnology research model in which the R&D activity of the participating regions is aligned with the needs of the companies or is the engine for the creation of these. That is, to promote the transfer of technology.

This project arises from the need to improve the weaknesses of the life cycle of a biotechnology product or service, in order to establish an effective research-to-market transition, turning it into a job and business opportunity.

The universities usually only face the first stages of the cycle and the results do not mature, being difficult to transfer to the business world through the usual mechanisms. It is exactly at this point that we want to act.

The robustness and guarantee of success of this project is based on the application of the results and experience acquired during its predecessors: BIÓPOLIS (announcement PIC INTERREG IIIC), BIOPHARMAC (MAC/1/C104) and BIOTRANSFER (MAC/3/C224). BIOTRANSFER2 will serve as a tool to encourage the maturation of research, which will increase the capacity and effectiveness of the region's technological transfer and will favour bio-entrepreneurship and creation of technology-based spin-off companies, by contributing to the development of a favourable collaboration environment that allows such transfer of research results.

It will also serve to consolidate and improve the connectivity, communication and collaborations established between the different agents of the science, technology and business system, which will ultimately favour interregional collaboration. The participation and interaction of Universities, Science-Technology Parks and the business sector, encompasses the environment where a large part of the R&D activity is coordinated, working together to favor the current low social return, generating local economic activity and therefore increase employment.

Added value of cooperation 

BIOTRANSFER2 stimulates and consolidates intersectoral cooperation between research centres and private companies, including, as a novelty, the use of intermediate agents such as Terceira and Tenerife Technological Science Parks (dynamic agents with territorial presence) and also stimulates cross-border cooperation (participating partners of different regions and countries), improving the competitiveness of the region and promoting regional and third-country development (Cabo Verde) through the transfer of knowledge, experience and results, guaranteeing a freer flow of knowledge.

BIOTRANSFER2 is a bet towards the generation of stable and lasting collaborations between public and private agents of different sectors and regions, based on a mutual benefit, improved capacities, education levels and knowledge infrastructure, and also increased private investment in biotechnology.

Main beneficiaries

Direct beneficiaries of this project, throughout the Macaronesian Region, are: researchers, research centres and universities; biotechnology-based companies, or susceptible to use biotechnology. However, we cannot ignore the indirect beneficiaries since promoting R&D&I is a clear strategy for the development of the entire regional and even international society. Transferring knowledge and research results between EU countries and third countries contributes greatly to the objectives set out in the strategies included in regional development policies, such as the national R&D plan (Spain) and the Ris3canarias. The promotion of the knowledge economy helps to improve the competitiveness of the Macaronesian economy in a globalized context and to diversify the local productive fabric to achieve the ultimate goal of economic and social sustainability in the region.

Geographical area of intervention of the project

The Project will be developed in the Canary Islands (Spain), Azores and Madeira (Portugal) and Cabo Verde, as priority third-country. The project joins the continents of Europe and Africa, encompassing the whole of Macaronesia. The project's area of influence is greater than 38,000 km2 around the Project Coordinator based on the Canary Islands.

Management and coordination

BIOTRANSFER2  will have a management system in which its evolution is controlled, by measuring and registering indicators on a regular basis. At the beginning of the project, an identification and monitorisation system will be implemented that will allow the state of execution of the project to be known. This system will include a tool to control costs, risks and incidents, in order to mitigate possible negative impacts on the project execution.

The work teams distributed among the participating countries will be coordinated through regular meetings with the Steering Committee (leader members of the partner institutions) and the Technical Committee (technicians from the partner institutions). The meetings will be held by videoconference and there will be, at least, one face-to-face meeting every year. Each regional leader will carry out a more exhaustive and exact monitoring of the state of the project, development of the activities and their results through work tables, meetings, conferences, etc, with partners and agents of interest detected by BIOTRANSFER2. In the case any deviations happen during any development phase of the project, the regional leader will inform the rest of the partners about the deviation, the possible causes and solutions to be carried out. In such way, a feedback system will be in place, that allows us to extrapolate solutions.

Decision making

As with the project preparation phase, decision-making will be carried out jointly with all project partners through the Steering Committee and the Technical Committee. The follow-up of each activity will be carried out, in the first instance, by each regional leader. As a second instance, the people in charge of each activity, will be responsible for overseeing the good performance of each of the actions and the identification and resolution of incidents or deviations, in the shortest possible time and with the greatest efficiency. When situations that could affect the adequate performance of the project are detected, a statement will be made to the heads of the partner entities and the matter will be addressed by videoconference, in order to redirect the project through joint decision making and consensus.